1. 261 Association of T-cell–inflamed gene expression profile and PD-L1 status with efficacy of pembrolizumab in patients with esophageal cancer from KEYNOTE-180. (9th November 2020) Authors: Shah, Manish; Kojima, Takashi; Hochhauser, Daniel; Enzinger, Peter; Raimbourg, Judith; Hollebecque, Antoine; Lordick, Florian; Kim, Sung-Bae; Tajika, Masahiro; Kim, Heung Tae; Craig Lockhart, A; Arkenau, Hendrick-Tobias; El-Hajbi, Farid; Pfeiffer, Per; Bhagia, Pooja; Alexander Cao, Z; Lunceford, ... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 5-Fluorouracil rechallenge after 5-fluorouracil-induced hyperammonemic encephalopathy. Issue 3 (March 2019) Authors: Boilève, Alice; Wicker, Camille; Verret, Benjamin; Leroy, Florence; Malka, David; Jozwiak, Mathieu; Pontoizeau, Clément; Ottolenghi, Chris; De Lonlay, Pascale; Ducreux, Michel; Hollebecque, Antoine Journal: Anti-cancer drugs Issue: Volume 30:Issue 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 5-Fluorouracil-induced hyperammonaemic encephalopathy: A French national survey. (April 2020) Authors: Boilève, Alice; Thomas, Laure; Lillo-Le Louët, Agnès; Gaboriau, Louise; Chouchana, Laurent; Ducreux, Michel; Malka, David; Boige, Valérie; Hollebecque, Antoine; Hillaire-Buys, Dominique; Jozwiak, Mathieu Journal: European journal of cancer Issue: Volume 129(2020) Page Start: 32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplification. (December 2017) Authors: Angevin, Eric; Spitaleri, Gianluca; Rodon, Jordi; Dotti, Katia; Isambert, Nicolas; Salvagni, Stefania; Moreno, Victor; Assadourian, Sylvie; Gomez, Corinne; Harnois, Marzia; Hollebecque, Antoine; Azaro, Analia; Hervieu, Alice; Rihawi, Karim; De Marinis, Filippo Journal: European journal of cancer Issue: Volume 87(2017) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Issue 9 (September 2018) Authors: Sun, Roger; Limkin, Elaine Johanna; Vakalopoulou, Maria; Dercle, Laurent; Champiat, Stéphane; Han, Shan Rong; Verlingue, Loïc; Brandao, David; Lancia, Andrea; Ammari, Samy; Hollebecque, Antoine; Scoazec, Jean-Yves; Marabelle, Aurélien; Massard, Christophe; Soria, Jean-Charles; Robert, Charlotte; ... Journal: Lancet oncology Issue: Volume 19:Issue 9(2018) Page Start: 1180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Absence of significant clinical benefit for a systematic routine creatine phosphokinase measurement in asymptomatic patients treated with anti-programmed death protein (ligand) 1 immune checkpoint inhibitor to screen cardiac or neuromuscular immune-related toxicities. (November 2021) Authors: Hajem, Samia; Ederhy, Stéphane; Champiat, Stéphane; Troalen, Frédéric; Nolin-Lapalme, Alexis; Berhoune, Malik; Cauquil, Cécile; Martin-Romano, Patricia; Baldini, Capucine; Laparra, Ariane; Vuagnat, Perrine; Hollebecque, Antoine; Mateus, Christine; Besse, Benjamin; Naltet, Charles; Robert, Carolin... Journal: European journal of cancer Issue: Volume 157(2021) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Advances in transarterial therapies for hepatocellular carcinoma: is novel technology leading to better outcomes?. (April 2016) Authors: de Baere, Thierry; Tselikas, Lambros; Deschamps, Frederic; Boige, Valerie; Ducreux, Michel; Hollebecque, Antoine Journal: Hepatic oncology Issue: Volume 3:Number 2(2016) Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. An appraisal of emerging second line therapies for metastatic colorectal cancer. (1st February 2021) Authors: Smolenschi, Cristina; Perret, Audrey; Dall'Armellina, François; Boige, Valerie; Malka, David; Hollebecque, Antoine; Ducreux, Michel Journal: Expert review of gastroenterology & hepatology Issue: Volume 15:Number 2(2021) Page Start: 165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Are phase I trials safe for older patients?. Issue 2 (March 2018) Authors: Baldini, Capucine; Le Saux, Olivia; Helissey, Carole; Aspeslagh, Sandrine; Castanon, Eduardo; Varga, Andrea; Gazzah, Anas; Bahleda, Rastilav; Mir, Olivier; Massard, Christophe; Soria, Jean-Charles; Hollebecque, Antoine Journal: Journal of geriatric oncology Issue: Volume 9:Issue 2(2018) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors). (October 2017) Authors: Sun, Roger; Champiat, Stéphane; Dercle, Laurent; Aspeslagh, Sandrine; Castanon, Eduardo; Limkin, Elaine Johanna; Baldini, Capucine; Postel-Vinay, Sophie; Hollebecque, Antoine; Massard, Christophe; Ammari, Samy; Deutsch, Eric; Soria, Jean-Charles; Marabelle, Aurélien; Ferté, Charles Journal: European journal of cancer Issue: Volume 84(2017) Page Start: 202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗